Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Researchers from Visterra present a novel humanized antibody against dengue virus

Sep. 30, 2014

ARN-2508, an orally available therapeutic for the potential treatment of pain and inflammation

Sep. 30, 2014

Bayer presents data from 11-year follow-up of the BENEFIT trials

Sep. 30, 2014

Genzyme presents promising data from 3-year follow up of CARE-MS I

Sep. 29, 2014

Reduced HYAL2 gene methylation in blood correlated with breast cancer

Sep. 29, 2014

Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors

Sep. 29, 2014

AstraZeneca discloses new FGFR-4 inhibitors

Sep. 29, 2014

Recessive variant found in PCD deficiency with MODY-like diabetes

Sep. 29, 2014

The effect of bisphosphonate compounds in animal models of acute colitis

Sep. 29, 2014

Selective monoacylglycerol lipase inhibitor improves experimental MS

Sep. 26, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...